Mentari Therapeutics, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MTRI and other ETFs, options, and stocks.About MTRI
InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (''CBN'') in diseases with high unmet medical needs. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines.
MTRI Key Statistics
Stock Snapshot
The current Mentari Therapeutics, Inc.(MTRI) stock price is $15.46, with a market capitalization of 84.93M. The stock trades at a price-to-earnings (P/E) ratio of -5.01.
On 2026-11-09, Mentari Therapeutics, Inc.(MTRI) stock moved within a range of $13.94 to $15.50. With shares now at $15.46, the stock is trading +10.9% above its intraday low and -0.3% below the session's peak.
Trading volume for Mentari Therapeutics, Inc.(MTRI) stock has reached 18.99K, versus its average volume of 15.63K.
Over the past 52 weeks, Mentari Therapeutics, Inc.(MTRI) stock has traded between a high of $23.30 and a low of $5.75.
Over the past 52 weeks, Mentari Therapeutics, Inc.(MTRI) stock has traded between a high of $23.30 and a low of $5.75.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.